Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
NCT07566286
This study is recruiting at 7 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Chin Augmentation
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Galderma R&D
- Last updated on ClinicalTrials.gov
- August 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- Galderma Investigational Site # 8680 · Westport, CT
Florida · 3
- Galderma Investigational Site # 8774 · Boynton Beach, FL
- Galderma Investigational Site # 7030 · Coral Gables, FL
- Galderma Investigational Site # 8682 · Coral Gables, FL
Georgia · 1
- Galderma Investigational Site # 7042 · Atlanta, GA
Tennessee · 1
- Galderma Investigational Site # 7118 · Nashville, TN
Texas · 1
- Galderma Investigational Site # 8662 · Spring, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.